Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLP-O Activators

The chemical class known as PLP-O Activators encompasses a diverse range of compounds that are understood to influence the activation of the protein PLP-O through various biochemical pathways. These activators are not directly interacting with the PLP-O protein but are involved in modulating the cellular signaling networks that can lead to its activation. The primary mechanisms of action for these activators involve the regulation of gene expression, modulation of upstream signaling molecules, and alterations in the cellular environment that favor the activation state of PLP-O.

Activators in this class engage with well-established cellular signaling cascades such as the JAK/STAT, MAPK, and PI3K/AKT pathways. By initiating a signaling cascade, these compounds can elicit a series of phosphorylation events or promote the translocation of transcription factors that ultimately enhance the expression or activity of PLP-O. Some activators work by increasing the concentration of secondary messengers like cAMP, which in turn activates protein kinases responsible for the phosphorylation of proteins that are upstream of PLP-O. Others may bind to specific receptors on the cell surface, triggering intracellular signaling pathways that culminate in the activation of PLP-O. Additionally, certain activators function by inhibiting phosphatases or other negative regulators within the pathways, thereby creating a cellular context that is conducive to PLP-O activation due to the sustained signaling input.

It's important to note that the efficacy of these activators can be influenced by the cellular context, such as the presence of specific co-factors, the activation state of related signaling proteins, and the overall health of the cell. The complexity of cellular signaling networks means that the impact of these activators on PLP-O is part of a dynamic and interconnected system. The precise role of each activator within this chemical class is determined by its unique chemical structure and the specific interactions it has with cellular components, which collectively contribute to the regulation of PLP-O activity within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

This hormone can modulate the expression of proteins related to the prolactin family by interacting with estrogen receptors and affecting gene transcription, which could possibly activate Prl7c1.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

This immunosuppressant can inhibit calcineurin, affecting the NFAT pathway, which may intersect with prolactin signaling cascades that could possibly activate Prl7c1.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

This diester activates protein kinase C (PKC) and can modulate numerous signaling pathways, potentially affecting Prl7c1 activation.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

This synthetic glucocorticoid can modulate gene expression through the glucocorticoid receptor, potentially influencing Prl7c1 activation.

Bromocriptine

25614-03-3sc-337602A
sc-337602B
sc-337602
10 mg
100 mg
1 g
$57.00
$265.00
$567.00
4
(1)

While typically a prolactin inhibitor, bromocriptine's actions on dopamine receptors may lead to complex feedback mechanisms that could possibly activate Prl7c1.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

As a regulator of gene expression, retinoic acid can influence numerous pathways including those that could possibly activate Prl7c1.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium can affect the GSK-3 pathway and alter various downstream signaling pathways, which could possibly activate Prl7c1.